Tau/Tau-P Ratio
Cerebrospinal fluid (CSF)

Tau/Tau-P Ratio is a cerebrospinal fluid (CSF) biomarker used to evaluate the relationship between total tau and phosphorylated tau (pTau), providing critical insights into the underlying pathology of neurodegenerative diseases, particularly Alzheimer’s disease. This ratio reflects both the extent of neuronal damage (indicated by total tau) and the degree of tau protein hyperphosphorylation (indicated by pTau). The Tau/Tau-P ratio enhances the diagnostic specificity of Alzheimer’s disease when interpreted alongside amyloid-beta (Aβ42) levels and other CSF biomarkers. It helps differentiate Alzheimer’s from other dementias or neurodegenerative conditions, making it a valuable tool in early diagnosis, treatment planning, and monitoring disease progression.

Taurine
Urine

Taurine is a crucial amino acid that serves multiple roles in the body: (1) It acts as a powerful antioxidant, helping to protect cells from damage caused by harmful molecules known as free radicals. (2) Taurine also aids in the regulation of minerals such as calcium within cells (3) and supports the healthy function of the heart and blood vessels. (4) Additionally, it is vital for the proper functioning of the brain and eyes. Unlike many other amino acids, taurine is not used to build proteins but rather helps in the development and function of various bodily systems. In the urinary amino acid panel, elevated or reduced levels of taurine can provide critical clues about a person’s dietary intake, ability to metabolize and absorb nutrients, and potential underlying health conditions. Low levels might indicate a deficiency potentially linked to dietary insufficiencies or metabolic disorders, while high levels could suggest supplementation or metabolic anomalies. Understanding taurine levels can help healthcare providers tailor nutritional support to meet individual health needs, optimizing overall wellbeing.